McCormick & Company in the news

Leidos, McCormick & Company, Halma, and Adecco Group announced new appointments and departures in their investor relations teams, alongside other IR role changes at Rheinmetall, QuidelOrtho, and DNB.

McCormick & Co. increased its 2026 inflation forecast to 7% due to rising freight and input costs, expecting continued inflation into 2027 despite some cost offsets and profit margin expansion in Q3.

McCormick's stock experienced a 16% decline in September due to rising food prices and analyst downgrades, despite a partial recovery after better-than-expected Q3 results.

McCormick is a global leader in spices, herbs, extracts, seasonings, and other flavorings, with a portfolio of well-known brands.

A McCormick director purchased $44,610 in company stock while the stock is near its 52-week low, following strong Q3 earnings despite some analyst price target adjustments.

Rockland Trust Co. increased its stake in McCormick & Company, which reported strong Q3 earnings, declared a dividend, and saw insider selling.

McCormick & Company reported better-than-expected Q3 fiscal 2026 results and reaffirmed its full-year outlook, while analysts reduced price targets.

McCormick & Co.'s third-quarter performance was buoyed by price increases and the acquisition of McCormick de Mexico, with sales rising to $2 billion despite a decline in earnings due to consumer spending pressures.

Analysts at UBS Group, among others, have lowered their price target for McCormick & Company to $48.00, despite the company reporting better-than-expected Q3 earnings and revenue.

Barclays reduced its price target for McCormick & Company to $47.00 with an "equal weight" rating, despite the company exceeding Q3 earnings and revenue estimates.

The article suggests McCormick, UnitedHealth Group, and Medtronic as three dividend-paying stocks that offer stability and income for investors in the current high-interest rate environment.

McCormick & Company's stock hit a new 52-week low despite exceeding Q3 earnings and revenue estimates, while organic growth remains low.

McCormick's Q3 growth was acquisition-driven with modest organic growth, while adjusted operating margin improved despite an overall operating margin decline, and future dividend growth may face constraints.

McCormick & Company reported strong Q3 earnings and revenue, beating analyst expectations, raised its FY26 guidance, and declared a quarterly dividend.

McCormick's Q3 financial results showed increased sales and profit due to price hikes, despite a slight dip in organic volumes and concerns about consumer spending.

McCormick & Company announced its earnings summary for the quarter that ended on August 31.

McCormick & Company is holding its Q3 2026 earnings call, where executives will discuss financial results and answer analyst questions.

McCormick's adjusted earnings and net sales exceeded analyst estimates, driven by organic growth, improved margins, and reaffirmed strong fiscal 2026 guidance.

McCormick & Company reported mixed earnings for Q3 and positive results for the nine months ended August 31, 2026, with increased sales but a drop in Q3 net income, while nine-month net income significantly rose.

McCormick & Company, Incorporated published its Q3 2026 earnings call presentation on October 1, 2026.